Unknown

Dataset Information

0

Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation.


ABSTRACT: Dysbiosis is commonly detected in patients with inflammatory bowel disease (IBD), supporting the concept that a dysregulated immune reaction to bacterial antigens has a pathogenic role in the development of intestinal inflammation. In the present study, we have investigated the beneficial effects of a novel probiotic formulation assembled by combining four probiotics (Streptococcus thermophilus, Lactobacillus casei, Bifidobacterium breve) with Bacillus subtilis, a Gram-positive bacterium, with extensive bio-applications. Mice rendered colitic by administration of TNBS or DSS were administered with Bacillus subtilis alone, Vivomixx® or the novel Five strains formulation. Vivomixx® attenuated the severity of inflammation and reduced the development of signs and symptoms of colitis in both models. Adding Bacillus subtilis to Vivomixx® improved the beneficial effects of the bacterial therapy. The novel Five strains formulation was as effective as Vivomixx® in reducing the development of signs and symptoms of colitis and reduced the expression of pro-inflammatory mediators including Il-6 and Tnf-? while increased the expression of Il-10 mRNA and the number of Treg. In summary, we have shown that a novel Five strains probiotics formulation exerts beneficial effects on two chemical models of colitis, establishing Bacillus subtilis as a probiotic in rodent models of inflammation.

SUBMITTER: Biagioli M 

PROVIDER: S-EPMC7400193 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation.

Biagioli Michele M   Carino Adriana A   Di Giorgio Cristina C   Marchianò Silvia S   Bordoni Martina M   Roselli Rosalinda R   Distrutti Eleonora E   Fiorucci Stefano S  

Nutrients 20200630 7


Dysbiosis is commonly detected in patients with inflammatory bowel disease (IBD), supporting the concept that a dysregulated immune reaction to bacterial antigens has a pathogenic role in the development of intestinal inflammation. In the present study, we have investigated the beneficial effects of a novel probiotic formulation assembled by combining four probiotics (<i>Streptococcus thermophilus</i>, <i>Lactobacillus casei</i>, <i>Bifidobacterium breve)</i> with <i>Bacillus subtilis</i>, a Gra  ...[more]

Similar Datasets

| S-EPMC2993169 | biostudies-literature
| S-EPMC10745623 | biostudies-literature
| S-EPMC8226750 | biostudies-literature
| S-EPMC9406415 | biostudies-literature
| S-EPMC7465986 | biostudies-literature
| S-EPMC4701830 | biostudies-other
| S-EPMC6853318 | biostudies-literature
| S-EPMC5434015 | biostudies-literature
| S-EPMC10617127 | biostudies-literature
| S-EPMC5242491 | biostudies-literature